CD47 blocking antibody accelerates hematoma clearance and alleviates hydrocephalus after experimental intraventricular hemorrhage.
CD47 blocking antibody accelerates hematoma clearance and alleviates hydrocephalus after experimental intraventricular hemorrhage.
复制标题
CD47阻断抗体会加速血肿清除,并在实验性脑室出血后减轻脑积水。
DOI:
10.1016/j.nbd.2021.105384
复制
发表时间:
2021-07
影响因子:
6.1
通讯作者:
Garton HJL
中科院分区:
文献类型:
--
作者:
Ye F;Hua Y;Keep RF;Xi G;Garton HJL
CD47, a glycoprotein on red blood cell membranes, inhibits phagocytosis via interaction with signal regulatory protein α on phagocytes. Our previous research has demonstrated that blocking CD47 accelerates hematoma clearance and reduces brain injury after intracerebral hemorrhage. The current study investigated whether phagocytosis or erythrocyte CD47 impacts hematoma resolution and hydrocephalus development after intraventricular hemorrhage (IVH). Adult (3-month-old) male Fischer 344 rats were intraventricularly injected with 200 μl autologous blood, mixed with either CD47 blocking antibody or isotype IgG, or 200 μl saline as control. In subgroups of CD47 blocking antibody treated rats, clodronate liposomes (to deplete microglia/monocyte-derived macrophages) or control liposomes were co-injected. Magnetic resonance imaging (MRI) was used to evaluate ventricular volume and intraventricular T2* lesion volume (estimating hematoma volume). The brains were harvested after 4 or 72 hours for histology to evaluate phagocytosis. In adult male rats, CD47 blocking antibody alleviated hydrocephalus development by day 3. In addition, the CD47 blocking antibody reduced intraventricular T2* lesion and T2* non-hypointense lesion size after IVH through day 1 to day 3. Erythrophagocytosis was observed as soon as 4 hours after IVH and was enhanced on day 3. Furthermore, intra-hematoma infiltration of CD68, heme oxygenase-1 and ferritin positive phagocytes were upregulated by CD47 blockade by day 3. Clodronate liposomes co-injection caused more severe hydrocephalus and weight loss. Blocking CD47 in the hematoma accelerated hematoma clearance and alleviated hemolysis and hydrocephalus development after IVH, suggesting CD47 might be valuable in the future treatment for IVH.
登录
查看更多内容
影响因子:
4.1
作者:
Rosen, David S.;Macdonald, R. Loch;Rosengart, Axel J.
通讯作者:
Rosengart, Axel J.
影响因子:
6.3
作者:
Gao, Chao;Du, Hanjian;Xi, Guohua
通讯作者:
Xi, Guohua
影响因子:
6.9
作者:
Dang G;Yang Y;Wu G;Hua Y;Keep RF;Xi G
通讯作者:
Xi G
DOI:
10.1016/s0140-6736(16)32410-2
发表时间:
2017-02-11
期刊:
Lancet (London, England)
影响因子:
--
作者:
Hanley DF;Lane K;McBee N;Ziai W;Tuhrim S;Lees KR;Dawson J;Gandhi D;Ullman N;Mould WA;Mayo SW;Mendelow AD;Gregson B;Butcher K;Vespa P;Wright DW;Kase CS;Carhuapoma JR;Keyl PM;Diener-West M;Muschelli J;Betz JF;Thompson CB;Sugar EA;Yenokyan G;Janis S;John S;Harnof S;Lopez GA;Aldrich EF;Harrigan MR;Ansari S;Jallo J;Caron JL;LeDoux D;Adeoye O;Zuccarello M;Adams HP Jr;Rosenblum M;Thompson RE;Awad IA;CLEAR III Investigators
通讯作者:
CLEAR III Investigators
影响因子:
8
作者:
Adams-Chapman, Ira;Hansen, Nellie I.;Higgins, Rose
通讯作者:
Higgins, Rose